Form 4: Marchex Inc. Chairman Russell C. Horowitz Reports Stock Option Grant

Russell C. Horowitz, Chairman of Marchex Inc., reports the acquisition of 50,000 stock options.

Summary

• Russell C. Horowitz, Chairman of Marchex Inc. [MCHX], filed a Form 4 on November 7, 2024, reporting a transaction.
• The transaction involved the acquisition of 50,000 employee stock options with an exercise price of $1.80 on November 6, 2024.
• These options vest 50% on November 6, 2025, and the remaining 50% on November 6, 2026, assuming continued service on the Board.
• Full vesting occurs upon a Change of Control event as defined in the option agreement.
• Following the reported transaction, Horowitz beneficially owns 50,000 derivative securities directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns management interests with shareholders.

Positives

• The grant of stock options to the Chairman aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the Board.

Industry Context

Stock option grants are a common practice to incentivize and retain key executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation, comparable to practices at companies like Zillow, Redfin, and Opendoor, which also utilize equity-based compensation to align executive incentives with company performance.
• The vesting schedule of 50% per year is fairly standard, similar to vesting schedules seen at other publicly traded technology companies.

Stakeholder Impact

• The stock option grant could have a slightly positive impact on shareholders by aligning the Chairman's interests with the company's long-term success.
• The option grant incentivizes the Chairman to remain with the company.

Key Dates